API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
21
PharmaCompass offers a list of Alprazolam API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Alprazolam manufacturer or Alprazolam supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Alprazolam manufacturer or Alprazolam supplier.
PharmaCompass also assists you with knowing the Alprazolam API Price utilized in the formulation of products. Alprazolam API Price is not always fixed or binding as the Alprazolam Price is obtained through a variety of data sources. The Alprazolam Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Alprazolam intensol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Alprazolam intensol, including repackagers and relabelers. The FDA regulates Alprazolam intensol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Alprazolam intensol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Alprazolam intensol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Alprazolam intensol supplier is an individual or a company that provides Alprazolam intensol active pharmaceutical ingredient (API) or Alprazolam intensol finished formulations upon request. The Alprazolam intensol suppliers may include Alprazolam intensol API manufacturers, exporters, distributors and traders.
click here to find a list of Alprazolam intensol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Alprazolam intensol DMF (Drug Master File) is a document detailing the whole manufacturing process of Alprazolam intensol active pharmaceutical ingredient (API) in detail. Different forms of Alprazolam intensol DMFs exist exist since differing nations have different regulations, such as Alprazolam intensol USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Alprazolam intensol DMF submitted to regulatory agencies in the US is known as a USDMF. Alprazolam intensol USDMF includes data on Alprazolam intensol's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Alprazolam intensol USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Alprazolam intensol suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Alprazolam intensol Drug Master File in Japan (Alprazolam intensol JDMF) empowers Alprazolam intensol API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Alprazolam intensol JDMF during the approval evaluation for pharmaceutical products. At the time of Alprazolam intensol JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Alprazolam intensol suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Alprazolam intensol Drug Master File in Korea (Alprazolam intensol KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Alprazolam intensol. The MFDS reviews the Alprazolam intensol KDMF as part of the drug registration process and uses the information provided in the Alprazolam intensol KDMF to evaluate the safety and efficacy of the drug.
After submitting a Alprazolam intensol KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Alprazolam intensol API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Alprazolam intensol suppliers with KDMF on PharmaCompass.
A Alprazolam intensol CEP of the European Pharmacopoeia monograph is often referred to as a Alprazolam intensol Certificate of Suitability (COS). The purpose of a Alprazolam intensol CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Alprazolam intensol EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Alprazolam intensol to their clients by showing that a Alprazolam intensol CEP has been issued for it. The manufacturer submits a Alprazolam intensol CEP (COS) as part of the market authorization procedure, and it takes on the role of a Alprazolam intensol CEP holder for the record. Additionally, the data presented in the Alprazolam intensol CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Alprazolam intensol DMF.
A Alprazolam intensol CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Alprazolam intensol CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Alprazolam intensol suppliers with CEP (COS) on PharmaCompass.
A Alprazolam intensol written confirmation (Alprazolam intensol WC) is an official document issued by a regulatory agency to a Alprazolam intensol manufacturer, verifying that the manufacturing facility of a Alprazolam intensol active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Alprazolam intensol APIs or Alprazolam intensol finished pharmaceutical products to another nation, regulatory agencies frequently require a Alprazolam intensol WC (written confirmation) as part of the regulatory process.
click here to find a list of Alprazolam intensol suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Alprazolam intensol as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Alprazolam intensol API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Alprazolam intensol as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Alprazolam intensol and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Alprazolam intensol NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Alprazolam intensol suppliers with NDC on PharmaCompass.
Alprazolam intensol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Alprazolam intensol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Alprazolam intensol GMP manufacturer or Alprazolam intensol GMP API supplier for your needs.
A Alprazolam intensol CoA (Certificate of Analysis) is a formal document that attests to Alprazolam intensol's compliance with Alprazolam intensol specifications and serves as a tool for batch-level quality control.
Alprazolam intensol CoA mostly includes findings from lab analyses of a specific batch. For each Alprazolam intensol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Alprazolam intensol may be tested according to a variety of international standards, such as European Pharmacopoeia (Alprazolam intensol EP), Alprazolam intensol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Alprazolam intensol USP).